Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram De Wilde

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Epigenetics|July 15, 2020
Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle studyRuben Van Paemel, Andries De Koker, Charlotte Vandeputte, et al.
Plos One|October 8, 2011
Practical tools to implement massive parallel pyrosequencing of PCR products in next generation molecular diagnosticsKim De Leeneer, Joachim De Schrijver, Lieven Clement, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 22, 2012
Complex genetics of radial ray deficiencies: screening of a cohort of 54 patientsSarah Vergult, A Jeannette M Hoogeboom, Emilia K Bijlsma, et al.
Oncotarget|March 2, 2018
The mutational landscape of <i>MYCN</i>, <i>Lin28b</i> and <i>ALK</i><sup></sup> driven murine neuroblastoma mimics human diseaseBram De Wilde, Anneleen Beckers, Sven Lindner, et al.
Journal of Medicinal Chemistry|November 18, 2025
Second-Generation AURKA-Targeting PROTACs: Structural Optimization toward in Vivo Degradation in NeuroblastomaSimon Krols, Muhammad Rishfi, Fien Martens, et al.
International Journal of Molecular Sciences|October 14, 2022
mRNA Capture Sequencing and RT-qPCR for the Detection of Pathognomonic, Novel, and Secondary Fusion Transcripts in FFPE Tissue: A Sarcoma ShowcaseAnneleen Decock, David Creytens, Steve Lefever, et al.
Scientific Reports|January 16, 2020
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressivenessLiselot M Mus, Irina Lambertz, Shana Claeys, et al.
Cell Death & Disease|February 25, 2026
Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitorsIris H Nelen, Soetkin Leys, Sarah-Lee Bekaert, et al.
NAR Cancer|December 1, 2022
Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models enables specific monitoring of tumour-derived extracellular RNAVanessa Vermeirssen, Jill Deleu, Annelien Morlion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Emergence of new ALK mutations at relapse of neuroblastomaGudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Epigenetics|July 15, 2020
Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle studyRuben Van Paemel, Andries De Koker, Charlotte Vandeputte, et al.
Plos One|October 8, 2011
Practical tools to implement massive parallel pyrosequencing of PCR products in next generation molecular diagnosticsKim De Leeneer, Joachim De Schrijver, Lieven Clement, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 22, 2012
Complex genetics of radial ray deficiencies: screening of a cohort of 54 patientsSarah Vergult, A Jeannette M Hoogeboom, Emilia K Bijlsma, et al.
Oncotarget|March 2, 2018
The mutational landscape of <i>MYCN</i>, <i>Lin28b</i> and <i>ALK</i><sup></sup> driven murine neuroblastoma mimics human diseaseBram De Wilde, Anneleen Beckers, Sven Lindner, et al.
Journal of Medicinal Chemistry|November 18, 2025
Second-Generation AURKA-Targeting PROTACs: Structural Optimization toward in Vivo Degradation in NeuroblastomaSimon Krols, Muhammad Rishfi, Fien Martens, et al.
International Journal of Molecular Sciences|October 14, 2022
mRNA Capture Sequencing and RT-qPCR for the Detection of Pathognomonic, Novel, and Secondary Fusion Transcripts in FFPE Tissue: A Sarcoma ShowcaseAnneleen Decock, David Creytens, Steve Lefever, et al.
Scientific Reports|January 16, 2020
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressivenessLiselot M Mus, Irina Lambertz, Shana Claeys, et al.
Cell Death & Disease|February 25, 2026
Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitorsIris H Nelen, Soetkin Leys, Sarah-Lee Bekaert, et al.
NAR Cancer|December 1, 2022
Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models enables specific monitoring of tumour-derived extracellular RNAVanessa Vermeirssen, Jill Deleu, Annelien Morlion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Emergence of new ALK mutations at relapse of neuroblastomaGudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, et al.
Pageof 7